Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis

被引:75
|
作者
Ward, MM
机构
[1] VA Palo Alto Hlth Care Syst 111G, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA
关键词
lupus nephritis; renal transplantation; end-stage renal disease; USRDS;
D O I
10.1046/j.1523-1755.2000.00065.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Although the outcomes of renal transplantation among patients with end-stage renal disease (ESRD) caused by lupus nephritis have generally been found to be comparable to those of patients with other causes of ESRD, some studies indicate that cadaveric graft failure is more common among these patients. However, most previous studies examined small numbers of patients and did not adjust for important confounding factors. Methods. Graft failure and patient mortality after the first cadaveric renal transplantation were compared between 772 adults with ESRD caused by lupus nephritis and 32,644 adults with ESRD caused by other causes who received a transplant between 1987 and 1994 and were included in the United States Renal Data System. The median follow-up times were 4.9 and 5.0 years in the two groups, respectively. Multivariate Cox regression models were used to adjust the risks of graft failure and mortality for group differences in recipient and donor characteristics. Similar comparisons were performed between 390 adults with ESRD caused by lupus nephritis and 10,512 adults with ESRD caused by other causes after first living-related renal transplantation. Results. In an unadjusted analysis, the risk of graft failure after first cadaveric transplant was slightly but significantly greater among patients with ESRD caused by lupus nephritis than among those with ESRD caused by other causes [hazard ratio (HR), 1.13; 95% CI, 1.01 to 1.26, P = 0.04]. However, after adjustment for potential confounding factors, the risk of graft failure was not increased in patients with ESRD caused by lupus nephritis (HR, 1.08; 95% CI, 0.94 to 1.23, P = 0.28). Mortality after the first cadaveric transplantation did not differ between groups. The adjusted risks of graft failure (HR, 1.06; 95% CI, 0.84 to 1.32, P = 0.62) and patient mortality (HR = 0.69; 95% CI, 0.45 to 1.05, P = 0.09) after the first living-related renal transplant were also not significantly higher among patients with ESRD caused by lupus nephritis. Conclusions. Graft and patient survival after first cadaveric and first living-related renal transplants are similar in patients with ESRD caused by lupus nephritis and patients with ESRD from other causes.
引用
收藏
页码:2136 / 2143
页数:8
相关论文
共 50 条
  • [11] Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis
    Ward, MM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) : 516 - 525
  • [12] Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis
    Pakchotanon, R.
    Gladman, D. D.
    Su, J.
    Urowitz, M. B.
    LUPUS, 2018, 27 (03) : 468 - 474
  • [13] End-stage renal disease in lupus: Disease activity, dialysis, and the outcome of transplantation
    Stone, JH
    LUPUS, 1998, 7 (09) : 654 - 659
  • [14] Effect of renal transplantation on haematological profile of patients with end-stage renal disease
    Islam, SI
    Ezeamuzie, CI
    Shaheen, FAM
    Sheikh, IA
    Masuda, QN
    Khaleel, MH
    SAUDI MEDICAL JOURNAL, 1995, 16 (05) : 410 - 417
  • [15] Clinical outcomes of kidney transplants on patients with end-stage renal disease secondary to lupus nephritis, polycystic kidney disease and diabetic nephropathy
    Fredy Nieto-Rios, John
    Maria Serna-Higuita, Lina
    Alexandra Builes-Rodriguez, Sheila
    Cesar Restrepo-Correa, Ricardo
    Aristizabal-Alzate, Arbey
    Ocampo-Kohn, Catalina
    Serna-Campuzano, Angelica
    Cardona-Diaz, Natalia
    Dario Giraldo-Ramirez, Nelson
    Adolfo Zuluaga-Valencia, Gustavo
    COLOMBIA MEDICA, 2016, 47 (01): : 51 - 58
  • [16] The evaluation of underlyin cardiovascular disease among patients with end-stage renal disease
    Hedayati, SS
    Szczech, LA
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2004, 11 (03) : 246 - 253
  • [17] Outcomes of dialysis and the transplantation options for patients with diabetic end-stage renal disease in Korea
    Jeon, Hee Jung
    Koo, Tai Yeon
    Han, Miyeun
    Kim, Ha Jin
    Jeong, Jong Cheol
    Park, Hyojun
    Ha, Jongwon
    Kim, Sung Joo
    Ahn, Curie
    Park, Jae Berm
    Yang, Jaeseok
    CLINICAL TRANSPLANTATION, 2016, 30 (05) : 534 - 544
  • [18] Renal ablation in patients with end-stage renal disease
    Hansch, A.
    Pfeil, A.
    Neumann, R.
    Neumann, S.
    Mayer, T. E.
    Wolf, G.
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2011, 40 (04) : 308 - 314
  • [19] Depression among patients with end-stage renal disease in hemodialysis
    Silva Junior, Geraldo B.
    Daher, Elizabeth F.
    Buosi, Ana Paula A.
    Lima, Rafael S. A.
    Lima, Mikaelly M.
    Silva, Eveline C.
    Sampaio, Aline M.
    Santana, Joao Moises L.
    Monteiro, Francisco Emmanuel C.
    Araujo, Snia M. H. A.
    PSYCHOLOGY HEALTH & MEDICINE, 2014, 19 (05) : 547 - 551
  • [20] Kidney transplantation for end-stage renal disease in lupus nephritis, a very safe procedure: a single Latin American transplant center experience
    Naranjo-Escobar, J.
    Manzi, E.
    Posada, J. G.
    Mesa, L.
    Echeverri, G. J.
    Duran, C.
    Schweneiberg, J.
    Caicedo, L. A.
    Villegas, J. I.
    Tobon, G. J.
    LUPUS, 2017, 26 (11) : 1157 - 1165